SCHEMBL7738154

SCHEMBL7738154

CC(C)[C@@H]1NC(=O)[C@@H](Cc2ccc(OCCCNC(=O)c3ccc(N/N=C/c4ccccc4S(=O)(=O)O)nc3)cc2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC1=O

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4A O75164 1/20 0.43
▸ ITGB3 P05106 5/20 0.42
▸ ITGAV P06756 5/20 0.42
▸ ITGB1 P05556 3/20 0.42
▸ ITGA5 P08648 3/20 0.42
▸ ITGB5 P18084 1/20 0.42
▸ CTSG P08311 2/20 0.41
▸ NNMT P40261 1/20 0.40
▸ PLAU P00749 1/20 0.40
▸ MC4R P32245 7/20 0.40
▸ MC5R P33032 7/20 0.40
▸ MC3R P41968 7/20 0.40
▸ MC1R Q01726 7/20 0.40
▸ AVPR2 P30518 1/20 0.39
▸ ITGB6 P18564 1/20 0.39
▸ ITGB8 P26012 1/20 0.39
▸ KEAP1 Q14145 1/20 0.39
▸ NFE2L2 Q16236 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7746128 1.00 KDM4A (0.43) KDM4AITGB3ITGAVITGB1ITGA5
SCHEMBL14585800 1.00 KDM4A (0.43) KDM4AITGB3ITGAVITGB1ITGA5
SCHEMBL7738161 0.96 KEAP1 (0.44) KDM4AITGB3ITGAVITGB1ITGA5
SCHEMBL14585823 0.94 AVPR2 (0.43) ITGB3ITGAVITGB1ITGA5ITGB5
SCHEMBL7743942 0.94 AVPR2 (0.43) ITGB3ITGAVITGB1ITGA5ITGB5
SCHEMBL14615561 0.94 AVPR2 (0.43) ITGB3ITGAVITGB1ITGA5ITGB5
SCHEMBL7738529 0.94 AVPR2 (0.43) ITGB3ITGAVITGB1ITGA5ITGB5
SCHEMBL14585827 0.94 AVPR2 (0.43) ITGB3ITGAVITGB1ITGA5ITGB5
SCHEMBL7746285 0.94 AVPR2 (0.43) ITGB3ITGAVITGB1ITGA5ITGB5
SCHEMBL14585812 0.93 ITGB3 (0.40) KDM4AITGB3ITGAVITGB1ITGA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6537520-B1 Diagnosis and treatment of cancer; kit containing compound having peptide or peptidomimetic functionality that binds to a alpha v beta 3 receptor linked to a chelator BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-03-25 — — US disclosed
Send feedback